Efficient TRAIL-R1/DR4-Mediated Apoptosis in Melanoma Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)

This publication has 45 references indexed in Scilit:

• Adenovirus E3-6.7K Protein Is Required in Conjunction with the E3-RID Protein Complex for the Internalization and Degradation of TRAIL Receptor 2
  Journal of Virology, 2004
• Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced Apoptosis
  Journal of Biological Chemistry, 2004
• CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants
  Oncogene, 2003
• Conditional expression of exogenous Bcl‐X_S triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts
  FEBS Letters, 2003
• TRAIL-Induced Apoptosis and Gene Induction in HaCaT Keratinocytes: Differential Contribution of TRAIL Receptors 1 and 2
  Journal of Investigative Dermatology, 2003
• Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas
  The Journal of Pathology, 2003
• Inducible Nitric Oxide Synthase is Expressed in Normal Human Melanocytes but Not in Melanoma Cells in Response to Tumor Necrosis Factor-α, Interferon-γ, and Lipopolysaccharide
  Journal of Investigative Dermatology, 2002
• Death and anti-death: tumour resistance to apoptosis
  Nature Reviews Cancer, 2002
• Downregulation of Endothelin B Receptor in Human Melanoma Cell Lines Parallel to Differentiation Genes
  Journal of Investigative Dermatology, 1999
• Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen
  International Journal of Cancer, 1988